 Peter Dempsey
Concepts (649)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ADAM Proteins | 25 | 2015 | 59 | 3.280 |
Why?
| | Amyloid Precursor Protein Secretases | 13 | 2021 | 76 | 2.360 |
Why?
| | Membrane Proteins | 19 | 2022 | 1048 | 1.830 |
Why?
| | Intestines | 7 | 2023 | 330 | 1.690 |
Why?
| | ADAM10 Protein | 15 | 2022 | 28 | 1.520 |
Why?
| | Stem Cell Niche | 3 | 2021 | 43 | 1.480 |
Why?
| | Cell Plasticity | 2 | 2021 | 24 | 1.470 |
Why?
| | Transforming Growth Factor alpha | 25 | 2013 | 53 | 1.420 |
Why?
| | ErbB Receptors | 27 | 2018 | 569 | 1.390 |
Why?
| | Receptors, Notch | 3 | 2020 | 85 | 1.280 |
Why?
| | Metalloendopeptidases | 13 | 2017 | 56 | 1.280 |
Why?
| | Breast Neoplasms | 27 | 2014 | 1957 | 1.210 |
Why?
| | Intercellular Signaling Peptides and Proteins | 14 | 2013 | 360 | 1.180 |
Why?
| | Ultrasonography, Mammary | 8 | 2010 | 11 | 1.050 |
Why?
| | Protein Precursors | 7 | 2010 | 126 | 1.010 |
Why?
| | Integrases | 2 | 2018 | 122 | 0.980 |
Why?
| | Organoids | 8 | 2023 | 75 | 0.930 |
Why?
| | Mammography | 17 | 2010 | 126 | 0.920 |
Why?
| | Breast | 11 | 2010 | 140 | 0.860 |
Why?
| | Paneth Cells | 3 | 2018 | 17 | 0.820 |
Why?
| | Intestinal Mucosa | 8 | 2023 | 529 | 0.810 |
Why?
| | Biopsy, Needle | 8 | 2010 | 188 | 0.780 |
Why?
| | Intestinal Neoplasms | 2 | 2018 | 23 | 0.720 |
Why?
| | ADAM17 Protein | 17 | 2022 | 31 | 0.720 |
Why?
| | alpha-Defensins | 1 | 2018 | 11 | 0.680 |
Why?
| | Parenteral Nutrition, Total | 2 | 2015 | 39 | 0.670 |
Why?
| | Signal Transduction | 25 | 2018 | 4688 | 0.650 |
Why?
| | Epidermal Growth Factor | 13 | 2015 | 172 | 0.590 |
Why?
| | Proteolysis | 1 | 2017 | 146 | 0.580 |
Why?
| | Carcinogenesis | 2 | 2018 | 181 | 0.580 |
Why?
| | Breast Diseases | 4 | 2010 | 20 | 0.530 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 83 | 0.520 |
Why?
| | Animals | 66 | 2023 | 33152 | 0.500 |
Why?
| | Regeneration | 3 | 2021 | 166 | 0.490 |
Why?
| | Mice | 43 | 2023 | 15446 | 0.490 |
Why?
| | Cell Membrane | 9 | 2017 | 700 | 0.490 |
Why?
| | Epithelial Cells | 11 | 2023 | 951 | 0.480 |
Why?
| | Carcinoma, Lobular | 4 | 2014 | 56 | 0.470 |
Why?
| | Gastrointestinal Tract | 1 | 2015 | 174 | 0.460 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2015 | 1159 | 0.460 |
Why?
| | Metalloproteases | 6 | 2017 | 38 | 0.460 |
Why?
| | Radiographic Image Enhancement | 3 | 2008 | 65 | 0.440 |
Why?
| | Neoplasms | 6 | 2017 | 2160 | 0.440 |
Why?
| | Stem Cells | 3 | 2020 | 556 | 0.410 |
Why?
| | Cell Line | 19 | 2014 | 2693 | 0.390 |
Why?
| | Radiology | 1 | 2014 | 199 | 0.380 |
Why?
| | Cell Proliferation | 10 | 2021 | 2262 | 0.380 |
Why?
| | Gene Targeting | 1 | 2010 | 80 | 0.370 |
Why?
| | Mass Screening | 5 | 2009 | 1048 | 0.360 |
Why?
| | Mice, Knockout | 12 | 2015 | 2664 | 0.360 |
Why?
| | Unnecessary Procedures | 1 | 2010 | 45 | 0.360 |
Why?
| | Tamoxifen | 1 | 2010 | 198 | 0.350 |
Why?
| | Inflammation | 5 | 2019 | 2545 | 0.330 |
Why?
| | Terminology as Topic | 2 | 2007 | 199 | 0.330 |
Why?
| | Radiographic Magnification | 1 | 2008 | 1 | 0.330 |
Why?
| | Stomach | 3 | 2009 | 103 | 0.320 |
Why?
| | Thinness | 1 | 2008 | 91 | 0.310 |
Why?
| | Growth Substances | 6 | 1999 | 136 | 0.300 |
Why?
| | Apoptosis | 10 | 2021 | 2461 | 0.290 |
Why?
| | Homeostasis | 2 | 2021 | 589 | 0.290 |
Why?
| | Hyperplasia | 3 | 2018 | 170 | 0.280 |
Why?
| | Peptide Fragments | 2 | 2010 | 700 | 0.280 |
Why?
| | Humans | 80 | 2021 | 118251 | 0.280 |
Why?
| | Insulin-Secreting Cells | 1 | 2010 | 327 | 0.280 |
Why?
| | Glycoproteins | 8 | 2008 | 317 | 0.280 |
Why?
| | Phenylmercuric Acetate | 2 | 2008 | 2 | 0.280 |
Why?
| | Transcriptional Activation | 6 | 2013 | 347 | 0.270 |
Why?
| | Muscle, Smooth, Vascular | 6 | 2008 | 455 | 0.270 |
Why?
| | Amino Acid Sequence | 12 | 2017 | 2063 | 0.260 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 306 | 0.260 |
Why?
| | Cell Lineage | 2 | 2018 | 316 | 0.250 |
Why?
| | Protein Processing, Post-Translational | 6 | 2007 | 408 | 0.240 |
Why?
| | Allyl Compounds | 2 | 2022 | 17 | 0.240 |
Why?
| | Protein Structure, Tertiary | 8 | 2010 | 822 | 0.230 |
Why?
| | beta Catenin | 2 | 2023 | 219 | 0.230 |
Why?
| | Sulfides | 2 | 2022 | 96 | 0.230 |
Why?
| | Energy Metabolism | 1 | 2008 | 762 | 0.220 |
Why?
| | Cell Differentiation | 7 | 2014 | 1746 | 0.220 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 4887 | 0.210 |
Why?
| | Betacellulin | 5 | 2010 | 7 | 0.210 |
Why?
| | Molecular Sequence Data | 11 | 2011 | 2855 | 0.210 |
Why?
| | Mice, Transgenic | 11 | 2020 | 2012 | 0.210 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 100 | 0.210 |
Why?
| | Dogs | 7 | 2011 | 369 | 0.200 |
Why?
| | Enzyme Inhibitors | 6 | 2008 | 817 | 0.200 |
Why?
| | Calcium | 5 | 2010 | 1151 | 0.200 |
Why?
| | Female | 40 | 2021 | 61261 | 0.190 |
Why?
| | Microscopy | 1 | 2022 | 124 | 0.190 |
Why?
| | Angiotensin II | 3 | 2008 | 107 | 0.190 |
Why?
| | Gamma Rays | 1 | 2021 | 52 | 0.190 |
Why?
| | Ultrasonography | 8 | 2009 | 714 | 0.190 |
Why?
| | Receptor, ErbB-4 | 3 | 2017 | 19 | 0.190 |
Why?
| | Immunohistochemistry | 6 | 2010 | 1681 | 0.180 |
Why?
| | Taste Buds | 1 | 2023 | 211 | 0.180 |
Why?
| | Doxorubicin | 3 | 2018 | 301 | 0.180 |
Why?
| | Colitis | 2 | 2019 | 219 | 0.180 |
Why?
| | Photolysis | 1 | 2020 | 80 | 0.180 |
Why?
| | Antiporters | 1 | 2019 | 16 | 0.180 |
Why?
| | Cell Movement | 4 | 2021 | 888 | 0.180 |
Why?
| | Radiation Injuries | 1 | 2021 | 131 | 0.180 |
Why?
| | Gastric Mucosa | 7 | 2009 | 45 | 0.180 |
Why?
| | Cell Survival | 2 | 2014 | 1045 | 0.170 |
Why?
| | History, 21st Century | 2 | 2014 | 170 | 0.170 |
Why?
| | Colon | 3 | 2017 | 237 | 0.170 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2021 | 175 | 0.170 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2018 | 18 | 0.170 |
Why?
| | History, 20th Century | 2 | 2014 | 281 | 0.170 |
Why?
| | Multipotent Stem Cells | 1 | 2018 | 18 | 0.170 |
Why?
| | Gene Deletion | 2 | 2018 | 359 | 0.170 |
Why?
| | Cell Dedifferentiation | 1 | 2018 | 30 | 0.170 |
Why?
| | Acidosis | 1 | 2019 | 84 | 0.170 |
Why?
| | Mitosis | 2 | 2018 | 172 | 0.160 |
Why?
| | Fibrosis | 1 | 2021 | 480 | 0.160 |
Why?
| | T-Lymphocytes | 4 | 2013 | 1770 | 0.160 |
Why?
| | Clone Cells | 1 | 2018 | 247 | 0.160 |
Why?
| | Sulfhydryl Compounds | 1 | 2020 | 179 | 0.160 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2021 | 210 | 0.160 |
Why?
| | Atrophy | 2 | 2015 | 164 | 0.160 |
Why?
| | Ligands | 8 | 2022 | 565 | 0.160 |
Why?
| | Leptin | 2 | 2010 | 228 | 0.160 |
Why?
| | Adhesins, Bacterial | 1 | 2017 | 34 | 0.160 |
Why?
| | Cysteine Endopeptidases | 1 | 2017 | 61 | 0.150 |
Why?
| | Cells, Cultured | 15 | 2019 | 4044 | 0.150 |
Why?
| | STAT3 Transcription Factor | 2 | 2018 | 186 | 0.150 |
Why?
| | Goblet Cells | 2 | 2014 | 17 | 0.150 |
Why?
| | Antineoplastic Agents | 2 | 2008 | 1967 | 0.150 |
Why?
| | Cell Polarity | 5 | 2003 | 133 | 0.150 |
Why?
| | Neutrophils | 2 | 2019 | 1142 | 0.150 |
Why?
| | Keratinocytes | 6 | 2010 | 227 | 0.150 |
Why?
| | Hydrogels | 2 | 2022 | 582 | 0.150 |
Why?
| | Adenoma | 1 | 2018 | 191 | 0.150 |
Why?
| | Endothelial Cells | 1 | 2022 | 717 | 0.140 |
Why?
| | Cytokines | 2 | 2015 | 1880 | 0.140 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2013 | 634 | 0.140 |
Why?
| | Receptor, ErbB-2 | 3 | 2007 | 320 | 0.140 |
Why?
| | Base Sequence | 6 | 2011 | 2148 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 2 | 2009 | 3169 | 0.140 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2008 | 236 | 0.140 |
Why?
| | Gene Expression Regulation | 4 | 2014 | 2435 | 0.140 |
Why?
| | Alleles | 1 | 2018 | 829 | 0.140 |
Why?
| | X-Ray Intensifying Screens | 2 | 2006 | 2 | 0.130 |
Why?
| | Sensitivity and Specificity | 5 | 2008 | 1787 | 0.130 |
Why?
| | Intestine, Small | 2 | 2018 | 130 | 0.130 |
Why?
| | Antibodies, Monoclonal | 7 | 2000 | 1279 | 0.130 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 104 | 0.130 |
Why?
| | Time Factors | 6 | 2014 | 6368 | 0.130 |
Why?
| | Receptor, Notch2 | 2 | 2011 | 14 | 0.130 |
Why?
| | Receptor, Notch1 | 2 | 2013 | 64 | 0.130 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2012 | 55 | 0.130 |
Why?
| | Enteroendocrine Cells | 1 | 2014 | 5 | 0.130 |
Why?
| | Phenotype | 4 | 2014 | 2937 | 0.120 |
Why?
| | Lateral Ventricles | 1 | 2014 | 22 | 0.120 |
Why?
| | B-Lymphocytes | 3 | 2010 | 767 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 980 | 0.120 |
Why?
| | Solubility | 3 | 2020 | 235 | 0.120 |
Why?
| | Neoplasm Staging | 5 | 2018 | 1221 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2018 | 685 | 0.120 |
Why?
| | Anesthesia, Local | 1 | 1993 | 17 | 0.120 |
Why?
| | ROC Curve | 4 | 2008 | 470 | 0.120 |
Why?
| | Pancreatic Neoplasms | 1 | 2021 | 727 | 0.120 |
Why?
| | Kidney | 4 | 2000 | 1351 | 0.120 |
Why?
| | Hydrolysis | 4 | 2010 | 176 | 0.110 |
Why?
| | Immunoreceptor Tyrosine-Based Activation Motif | 1 | 2013 | 1 | 0.110 |
Why?
| | Cell Nucleus | 3 | 2018 | 577 | 0.110 |
Why?
| | Gastritis, Hypertrophic | 1 | 1992 | 3 | 0.110 |
Why?
| | Probiotics | 1 | 2013 | 48 | 0.110 |
Why?
| | Cadherins | 1 | 2014 | 186 | 0.110 |
Why?
| | Tumor Cells, Cultured | 6 | 2021 | 871 | 0.110 |
Why?
| | Neural Stem Cells | 1 | 2014 | 120 | 0.110 |
Why?
| | Diagnosis, Differential | 3 | 2007 | 1379 | 0.110 |
Why?
| | Protease Inhibitors | 3 | 2012 | 101 | 0.110 |
Why?
| | CD3 Complex | 1 | 2013 | 93 | 0.110 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2017 | 290 | 0.110 |
Why?
| | Skin | 3 | 2010 | 657 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 330 | 0.110 |
Why?
| | Protein Kinase C | 4 | 2003 | 294 | 0.110 |
Why?
| | Reproducibility of Results | 5 | 2020 | 2855 | 0.100 |
Why?
| | Macrophages | 2 | 2017 | 1311 | 0.100 |
Why?
| | EGF Family of Proteins | 6 | 2008 | 15 | 0.100 |
Why?
| | Amphiregulin | 6 | 2008 | 21 | 0.100 |
Why?
| | Blotting, Western | 4 | 2008 | 1186 | 0.100 |
Why?
| | Genes, ras | 3 | 1998 | 95 | 0.100 |
Why?
| | Cell Division | 7 | 2004 | 775 | 0.100 |
Why?
| | Ultrasonography, Interventional | 3 | 2010 | 155 | 0.100 |
Why?
| | Extracellular Matrix | 3 | 2022 | 444 | 0.100 |
Why?
| | Protein Kinase C-delta | 3 | 2008 | 68 | 0.100 |
Why?
| | Biopsy, Fine-Needle | 2 | 2009 | 69 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2020 | 403 | 0.100 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 279 | 0.100 |
Why?
| | Galactosides | 1 | 2010 | 3 | 0.100 |
Why?
| | Presenilin-2 | 1 | 2010 | 4 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2010 | 39 | 0.090 |
Why?
| | Lipoylation | 1 | 2010 | 16 | 0.090 |
Why?
| | Crosses, Genetic | 1 | 2010 | 138 | 0.090 |
Why?
| | Presenilin-1 | 1 | 2010 | 29 | 0.090 |
Why?
| | Recovery of Function | 1 | 2014 | 603 | 0.090 |
Why?
| | Receptors, IgE | 1 | 2010 | 40 | 0.090 |
Why?
| | Hydrogen Peroxide | 3 | 2006 | 302 | 0.090 |
Why?
| | Peptides | 1 | 1995 | 879 | 0.090 |
Why?
| | TRPV Cation Channels | 1 | 2010 | 30 | 0.090 |
Why?
| | Hair | 1 | 2010 | 68 | 0.090 |
Why?
| | Transfection | 6 | 2006 | 887 | 0.090 |
Why?
| | Male | 14 | 2017 | 57474 | 0.090 |
Why?
| | Genes, Reporter | 1 | 2010 | 268 | 0.090 |
Why?
| | Adult | 16 | 2010 | 31324 | 0.090 |
Why?
| | Antigens, CD | 3 | 2007 | 457 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2018 | 1161 | 0.080 |
Why?
| | Radiography | 3 | 2014 | 860 | 0.080 |
Why?
| | Helicobacter Infections | 1 | 2009 | 25 | 0.080 |
Why?
| | Kinetics | 4 | 2005 | 1623 | 0.080 |
Why?
| | Uncoupling Protein 1 | 1 | 2008 | 16 | 0.080 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2008 | 14 | 0.080 |
Why?
| | Fats | 1 | 2008 | 13 | 0.080 |
Why?
| | Immunoglobulin G | 2 | 2010 | 785 | 0.080 |
Why?
| | Middle Aged | 14 | 2007 | 27510 | 0.080 |
Why?
| | Calcinosis | 2 | 2006 | 282 | 0.080 |
Why?
| | Disintegrins | 2 | 2007 | 5 | 0.080 |
Why?
| | Cell Line, Tumor | 5 | 2018 | 2837 | 0.080 |
Why?
| | Fluorescent Dyes | 1 | 2010 | 313 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2006 | 1385 | 0.080 |
Why?
| | HEK293 Cells | 3 | 2017 | 625 | 0.080 |
Why?
| | Ion Channels | 1 | 2008 | 125 | 0.080 |
Why?
| | Enzyme Precursors | 1 | 2007 | 15 | 0.080 |
Why?
| | Swine | 1 | 2010 | 719 | 0.080 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2006 | 192 | 0.080 |
Why?
| | Intercellular Junctions | 2 | 2000 | 34 | 0.080 |
Why?
| | Isoenzymes | 2 | 2000 | 297 | 0.080 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2007 | 35 | 0.080 |
Why?
| | Bacterial Proteins | 1 | 2013 | 762 | 0.080 |
Why?
| | Lymphocyte Activation | 2 | 2013 | 1062 | 0.080 |
Why?
| | Hypothalamus | 1 | 2008 | 155 | 0.080 |
Why?
| | Efficiency | 1 | 2008 | 88 | 0.080 |
Why?
| | Disease Models, Animal | 5 | 2019 | 3676 | 0.080 |
Why?
| | Observer Variation | 1 | 2008 | 306 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2007 | 104 | 0.070 |
Why?
| | Colorectal Neoplasms | 2 | 2018 | 628 | 0.070 |
Why?
| | Adipocytes | 1 | 2008 | 195 | 0.070 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2000 | 317 | 0.070 |
Why?
| | Heparin-binding EGF-like Growth Factor | 3 | 2013 | 11 | 0.070 |
Why?
| | Early Detection of Cancer | 1 | 2010 | 360 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2008 | 224 | 0.070 |
Why?
| | United States | 3 | 2014 | 12488 | 0.070 |
Why?
| | Receptor, ErbB-3 | 1 | 2006 | 42 | 0.070 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 220 | 0.070 |
Why?
| | Phosphorylation | 6 | 2013 | 1622 | 0.070 |
Why?
| | Cell Line, Transformed | 2 | 2004 | 135 | 0.070 |
Why?
| | Eating | 1 | 2008 | 366 | 0.070 |
Why?
| | Tyrosine | 3 | 2008 | 227 | 0.070 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2005 | 8 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2004 | 817 | 0.070 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 109 | 0.070 |
Why?
| | Neoplasm, Residual | 1 | 2006 | 103 | 0.070 |
Why?
| | Receptors, Progesterone | 1 | 2007 | 325 | 0.070 |
Why?
| | Fibromatosis, Aggressive | 1 | 2005 | 19 | 0.070 |
Why?
| | Nucleoside-Phosphate Kinase | 1 | 2005 | 1 | 0.070 |
Why?
| | Colonic Neoplasms | 2 | 1999 | 224 | 0.060 |
Why?
| | RNA, Messenger | 7 | 2018 | 2657 | 0.060 |
Why?
| | Endothelin-1 | 1 | 2006 | 167 | 0.060 |
Why?
| | Organ Culture Techniques | 3 | 2014 | 149 | 0.060 |
Why?
| | Biological Transport | 3 | 2008 | 380 | 0.060 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 386 | 0.060 |
Why?
| | Ion Transport | 1 | 2004 | 59 | 0.060 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2006 | 360 | 0.060 |
Why?
| | GTP-Binding Proteins | 1 | 2005 | 147 | 0.060 |
Why?
| | Gastric Acid | 2 | 1995 | 15 | 0.060 |
Why?
| | Physical Examination | 1 | 2006 | 242 | 0.060 |
Why?
| | Neurons | 1 | 2012 | 1340 | 0.060 |
Why?
| | Chemokines, CXC | 1 | 2004 | 61 | 0.060 |
Why?
| | Heparin | 1 | 2005 | 230 | 0.060 |
Why?
| | Mutation | 5 | 2010 | 3435 | 0.060 |
Why?
| | Leiomyosarcoma | 1 | 2003 | 23 | 0.060 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 40 | 0.060 |
Why?
| | Up-Regulation | 2 | 2019 | 862 | 0.060 |
Why?
| | DNA Primers | 1 | 2004 | 532 | 0.060 |
Why?
| | Motor Activity | 1 | 2008 | 664 | 0.060 |
Why?
| | Receptor Protein-Tyrosine Kinases | 2 | 2003 | 229 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2004 | 288 | 0.060 |
Why?
| | Rats | 8 | 2008 | 5339 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2007 | 709 | 0.060 |
Why?
| | Aged | 8 | 2007 | 19594 | 0.060 |
Why?
| | Mammary Glands, Animal | 2 | 1995 | 122 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 206 | 0.060 |
Why?
| | Uterine Neoplasms | 1 | 2003 | 76 | 0.060 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 200 | 0.050 |
Why?
| | Molecular Weight | 2 | 1997 | 340 | 0.050 |
Why?
| | Tongue | 1 | 2023 | 73 | 0.050 |
Why?
| | Leucine | 1 | 2003 | 117 | 0.050 |
Why?
| | Receptors, Cell Surface | 2 | 2022 | 362 | 0.050 |
Why?
| | Cysts | 2 | 1992 | 93 | 0.050 |
Why?
| | Cytoplasm | 1 | 2003 | 269 | 0.050 |
Why?
| | Immunoenzyme Techniques | 4 | 2003 | 195 | 0.050 |
Why?
| | Epithelium | 3 | 1995 | 303 | 0.050 |
Why?
| | Gene Knockdown Techniques | 2 | 2013 | 312 | 0.050 |
Why?
| | Morphogenesis | 1 | 2023 | 166 | 0.050 |
Why?
| | Dandy-Walker Syndrome | 1 | 1981 | 7 | 0.050 |
Why?
| | Women's Health | 1 | 2004 | 274 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2023 | 174 | 0.050 |
Why?
| | Prevalence | 1 | 2008 | 2321 | 0.050 |
Why?
| | Protein Transport | 1 | 2003 | 407 | 0.050 |
Why?
| | Milk Proteins | 2 | 1995 | 37 | 0.050 |
Why?
| | Prognosis | 2 | 2021 | 3424 | 0.050 |
Why?
| | Brain | 2 | 2010 | 2481 | 0.050 |
Why?
| | Ephrin-B2 | 1 | 2021 | 42 | 0.050 |
Why?
| | Enzyme Activation | 3 | 2013 | 810 | 0.050 |
Why?
| | Precipitin Tests | 3 | 2004 | 94 | 0.050 |
Why?
| | Hydrocephalus | 1 | 1981 | 81 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2005 | 725 | 0.050 |
Why?
| | Phenylalanine | 2 | 1998 | 66 | 0.050 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 2000 | 11 | 0.050 |
Why?
| | Insulin | 1 | 2010 | 2157 | 0.050 |
Why?
| | Shear Strength | 1 | 2020 | 55 | 0.050 |
Why?
| | Quinazolines | 2 | 2015 | 245 | 0.050 |
Why?
| | Fetal Diseases | 1 | 1981 | 148 | 0.050 |
Why?
| | Thiophenes | 2 | 1998 | 106 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2000 | 79 | 0.050 |
Why?
| | Neovascularization, Pathologic | 1 | 2022 | 286 | 0.050 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2019 | 19 | 0.050 |
Why?
| | Fibroblasts | 2 | 2002 | 835 | 0.050 |
Why?
| | Leukocyte Disorders | 1 | 2019 | 10 | 0.050 |
Why?
| | Brain Diseases | 1 | 1981 | 141 | 0.050 |
Why?
| | Prenatal Diagnosis | 1 | 1981 | 167 | 0.050 |
Why?
| | Rheology | 1 | 2020 | 86 | 0.040 |
Why?
| | Proteins | 3 | 2005 | 935 | 0.040 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2019 | 27 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2019 | 35 | 0.040 |
Why?
| | Carcinoma | 2 | 1995 | 204 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 406 | 0.040 |
Why?
| | Neutrophil Activation | 1 | 2019 | 83 | 0.040 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1999 | 9 | 0.040 |
Why?
| | Autocrine Communication | 1 | 1999 | 42 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 618 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 418 | 0.040 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 1999 | 43 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2020 | 215 | 0.040 |
Why?
| | Vanadates | 1 | 1998 | 29 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1999 | 111 | 0.040 |
Why?
| | Genes, p53 | 1 | 1998 | 64 | 0.040 |
Why?
| | Pain | 2 | 1993 | 736 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2007 | 6541 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2021 | 737 | 0.040 |
Why?
| | Mucin-2 | 1 | 2017 | 3 | 0.040 |
Why?
| | Glycosylation | 1 | 1998 | 129 | 0.040 |
Why?
| | Retrospective Studies | 5 | 2007 | 12929 | 0.040 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1998 | 139 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2022 | 378 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2000 | 303 | 0.040 |
Why?
| | Adenosine | 1 | 2019 | 211 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 1998 | 78 | 0.040 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2018 | 31 | 0.040 |
Why?
| | Cell Adhesion | 3 | 2014 | 435 | 0.040 |
Why?
| | Mutagenesis | 1 | 1998 | 176 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2018 | 108 | 0.040 |
Why?
| | Light | 1 | 2020 | 340 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2007 | 1857 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 4521 | 0.040 |
Why?
| | Receptor, Angiotensin, Type 1 | 2 | 2008 | 22 | 0.040 |
Why?
| | Dipeptides | 2 | 2008 | 51 | 0.040 |
Why?
| | DNA, Complementary | 2 | 2010 | 265 | 0.040 |
Why?
| | Graft Rejection | 1 | 2000 | 548 | 0.040 |
Why?
| | Neuregulins | 1 | 2017 | 7 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2017 | 56 | 0.040 |
Why?
| | Hypertrophy | 2 | 2008 | 121 | 0.040 |
Why?
| | Transcription, Genetic | 4 | 2000 | 1322 | 0.040 |
Why?
| | Extracellular Space | 1 | 1997 | 127 | 0.040 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 1997 | 61 | 0.040 |
Why?
| | Tumor Burden | 1 | 2018 | 275 | 0.040 |
Why?
| | Prostaglandins | 1 | 1997 | 78 | 0.040 |
Why?
| | Spleen | 2 | 2010 | 504 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 1716 | 0.040 |
Why?
| | Models, Biological | 2 | 2020 | 1701 | 0.040 |
Why?
| | Foreign Bodies | 1 | 1997 | 98 | 0.030 |
Why?
| | COS Cells | 2 | 2007 | 184 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2008 | 4684 | 0.030 |
Why?
| | Neoplasm Invasiveness | 2 | 2007 | 460 | 0.030 |
Why?
| | Mice, Inbred DBA | 2 | 1994 | 172 | 0.030 |
Why?
| | Catheterization, Central Venous | 1 | 1997 | 95 | 0.030 |
Why?
| | CHO Cells | 2 | 2007 | 142 | 0.030 |
Why?
| | Cricetinae | 2 | 2007 | 261 | 0.030 |
Why?
| | Cyclophosphamide | 2 | 2006 | 222 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2019 | 501 | 0.030 |
Why?
| | Uterus | 1 | 1977 | 197 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 541 | 0.030 |
Why?
| | Fluorouracil | 2 | 2006 | 150 | 0.030 |
Why?
| | Repressor Proteins | 1 | 1998 | 378 | 0.030 |
Why?
| | Transforming Growth Factor beta | 2 | 1995 | 461 | 0.030 |
Why?
| | Paclitaxel | 2 | 2006 | 193 | 0.030 |
Why?
| | Immunoblotting | 2 | 2008 | 304 | 0.030 |
Why?
| | Caco-2 Cells | 3 | 1999 | 66 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 1994 | 49 | 0.030 |
Why?
| | Genes, Dominant | 2 | 2006 | 96 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 1975 | 116 | 0.030 |
Why?
| | Wiskott-Aldrich Syndrome Protein Family | 1 | 2014 | 3 | 0.030 |
Why?
| | 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase | 1 | 2014 | 5 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2000 | 672 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2000 | 979 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1994 | 63 | 0.030 |
Why?
| | Myelin Proteins | 1 | 2014 | 45 | 0.030 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2014 | 13 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 2014 | 45 | 0.030 |
Why?
| | Age Factors | 3 | 2009 | 2990 | 0.030 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1994 | 63 | 0.030 |
Why?
| | Proteoglycans | 1 | 2014 | 109 | 0.030 |
Why?
| | Demyelinating Diseases | 1 | 2014 | 79 | 0.030 |
Why?
| | Liver Regeneration | 1 | 1993 | 34 | 0.030 |
Why?
| | Lidocaine | 1 | 1993 | 42 | 0.030 |
Why?
| | Radiology, Interventional | 1 | 1993 | 28 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 1993 | 139 | 0.030 |
Why?
| | Mitogens | 1 | 1993 | 57 | 0.030 |
Why?
| | Adenoviridae | 2 | 2005 | 191 | 0.030 |
Why?
| | Gene Expression | 2 | 1998 | 1482 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-vav | 1 | 2013 | 1 | 0.030 |
Why?
| | Risk Factors | 4 | 2010 | 8958 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1994 | 174 | 0.030 |
Why?
| | Hydroxamic Acids | 2 | 2006 | 80 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1994 | 541 | 0.030 |
Why?
| | Metallothionein | 1 | 1992 | 24 | 0.030 |
Why?
| | Menstrual Cycle | 1 | 1993 | 113 | 0.030 |
Why?
| | Stomach Diseases | 1 | 1992 | 17 | 0.030 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2012 | 22 | 0.030 |
Why?
| | Keratins | 1 | 1993 | 174 | 0.030 |
Why?
| | Antigens | 1 | 2014 | 319 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2010 | 1302 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1004 | 0.030 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 1992 | 41 | 0.030 |
Why?
| | Contrast Media | 1 | 1975 | 373 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 1977 | 447 | 0.030 |
Why?
| | Retroviridae | 2 | 2005 | 89 | 0.030 |
Why?
| | Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 6 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 287 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 115 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2015 | 735 | 0.030 |
Why?
| | Pregnancy | 3 | 1995 | 5671 | 0.020 |
Why?
| | Preoperative Care | 1 | 1993 | 332 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 538 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 116 | 0.020 |
Why?
| | Genes, BRCA2 | 1 | 2010 | 25 | 0.020 |
Why?
| | Genes, BRCA1 | 1 | 2010 | 31 | 0.020 |
Why?
| | Homeodomain Proteins | 2 | 2007 | 469 | 0.020 |
Why?
| | Receptors, CCR1 | 1 | 2010 | 2 | 0.020 |
Why?
| | Preoperative Period | 1 | 2010 | 109 | 0.020 |
Why?
| | Body Fluids | 1 | 2010 | 62 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 3 | 2003 | 2434 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 219 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 144 | 0.020 |
Why?
| | SEER Program | 1 | 2010 | 205 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2005 | 394 | 0.020 |
Why?
| | Gene Amplification | 1 | 2010 | 97 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 159 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1990 | 142 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 1987 | 329 | 0.020 |
Why?
| | Exons | 1 | 2010 | 306 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2010 | 173 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2012 | 415 | 0.020 |
Why?
| | Alabama | 1 | 1988 | 24 | 0.020 |
Why?
| | bcl-2-Associated X Protein | 1 | 2009 | 46 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2009 | 31 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2000 | 367 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2010 | 178 | 0.020 |
Why?
| | Tyrphostins | 1 | 2008 | 16 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 850 | 0.020 |
Why?
| | DNA | 4 | 1999 | 1385 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2008 | 52 | 0.020 |
Why?
| | Epitopes | 2 | 1990 | 439 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 2008 | 74 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2008 | 14 | 0.020 |
Why?
| | Caspase 3 | 1 | 2009 | 240 | 0.020 |
Why?
| | Skin Neoplasms | 1 | 1995 | 762 | 0.020 |
Why?
| | Exocytosis | 1 | 2008 | 88 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 225 | 0.020 |
Why?
| | Axilla | 1 | 2007 | 56 | 0.020 |
Why?
| | Laminin | 1 | 1987 | 68 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1994 | 807 | 0.020 |
Why?
| | Premenopause | 1 | 2007 | 107 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 90 | 0.020 |
Why?
| | Mice, Inbred BALB C | 3 | 1995 | 1202 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1157 | 0.020 |
Why?
| | Cricetulus | 1 | 2007 | 98 | 0.020 |
Why?
| | Calcimycin | 1 | 2006 | 57 | 0.020 |
Why?
| | Fibronectins | 1 | 1987 | 114 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2008 | 345 | 0.020 |
Why?
| | Fixatives | 1 | 1986 | 16 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 306 | 0.020 |
Why?
| | Growth and Development | 1 | 2006 | 6 | 0.020 |
Why?
| | Histocytochemistry | 1 | 1986 | 82 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2006 | 121 | 0.020 |
Why?
| | Artifacts | 1 | 2006 | 125 | 0.020 |
Why?
| | Antigens, Surface | 1 | 1986 | 156 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2006 | 139 | 0.020 |
Why?
| | Binding Sites | 2 | 2005 | 1221 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2007 | 244 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2006 | 139 | 0.020 |
Why?
| | Organ Specificity | 1 | 1986 | 274 | 0.020 |
Why?
| | Ionophores | 1 | 2005 | 25 | 0.020 |
Why?
| | Specimen Handling | 1 | 2006 | 163 | 0.020 |
Why?
| | Lac Operon | 1 | 2005 | 47 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2006 | 140 | 0.020 |
Why?
| | Aorta | 1 | 2008 | 364 | 0.020 |
Why?
| | Guanylate Kinases | 1 | 2005 | 14 | 0.020 |
Why?
| | Liver | 1 | 1993 | 1803 | 0.020 |
Why?
| | Type C Phospholipases | 1 | 2005 | 66 | 0.020 |
Why?
| | Rabbits | 1 | 2006 | 779 | 0.020 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 58 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2006 | 400 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2014 | 4574 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2003 | 1937 | 0.020 |
Why?
| | Guinea Pigs | 2 | 1996 | 151 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2005 | 158 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1082 | 0.020 |
Why?
| | Chemokine CXCL6 | 1 | 2004 | 2 | 0.020 |
Why?
| | Chemokine CXCL16 | 1 | 2004 | 4 | 0.020 |
Why?
| | Receptors, Scavenger | 1 | 2004 | 17 | 0.020 |
Why?
| | Culture Media, Conditioned | 2 | 1995 | 108 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2004 | 96 | 0.010 |
Why?
| | RNA | 1 | 2010 | 830 | 0.010 |
Why?
| | Neoadjuvant Therapy | 1 | 2006 | 333 | 0.010 |
Why?
| | Cytodiagnosis | 1 | 2003 | 27 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2003 | 153 | 0.010 |
Why?
| | Acetophenones | 1 | 2003 | 14 | 0.010 |
Why?
| | Benzopyrans | 1 | 2003 | 25 | 0.010 |
Why?
| | Catalysis | 1 | 2004 | 295 | 0.010 |
Why?
| | Janus Kinase 2 | 1 | 2003 | 32 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 1986 | 359 | 0.010 |
Why?
| | Neutralization Tests | 2 | 1995 | 64 | 0.010 |
Why?
| | Radioimmunoassay | 2 | 1993 | 164 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 302 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2005 | 571 | 0.010 |
Why?
| | Fetus | 1 | 1986 | 690 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2005 | 650 | 0.010 |
Why?
| | Cranial Fossa, Posterior | 1 | 1981 | 17 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2004 | 562 | 0.010 |
Why?
| | B7-2 Antigen | 1 | 2000 | 25 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 45 | 0.010 |
Why?
| | Immune Sera | 1 | 2000 | 82 | 0.010 |
Why?
| | CD28 Antigens | 1 | 2000 | 46 | 0.010 |
Why?
| | Antibodies, Blocking | 1 | 2000 | 32 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 2000 | 108 | 0.010 |
Why?
| | Lymphopenia | 1 | 2000 | 48 | 0.010 |
Why?
| | CD40 Ligand | 1 | 2000 | 44 | 0.010 |
Why?
| | B7-1 Antigen | 1 | 2000 | 69 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 2000 | 121 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2000 | 209 | 0.010 |
Why?
| | Oncogene Protein v-crk | 1 | 2000 | 1 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p130 | 1 | 2000 | 2 | 0.010 |
Why?
| | Receptor Cross-Talk | 1 | 2000 | 22 | 0.010 |
Why?
| | Genes, src | 1 | 2000 | 5 | 0.010 |
Why?
| | Crk-Associated Substrate Protein | 1 | 2000 | 5 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 155 | 0.010 |
Why?
| | Retinoblastoma Protein | 1 | 2000 | 52 | 0.010 |
Why?
| | src Homology Domains | 1 | 2000 | 34 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2001 | 201 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2003 | 935 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 274 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1590 | 0.010 |
Why?
| | Epidermis | 1 | 2000 | 152 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 174 | 0.010 |
Why?
| | Protein Binding | 1 | 2005 | 1969 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2000 | 334 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 1999 | 4 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2000 | 146 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 2000 | 412 | 0.010 |
Why?
| | Drug Resistance, Multiple | 1 | 1999 | 19 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 1999 | 27 | 0.010 |
Why?
| | Carcinogenicity Tests | 1 | 1998 | 5 | 0.010 |
Why?
| | Ribonucleases | 1 | 1999 | 53 | 0.010 |
Why?
| | CCN Intercellular Signaling Proteins | 1 | 1998 | 5 | 0.010 |
Why?
| | Thiocarbamates | 1 | 1998 | 7 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 1998 | 83 | 0.010 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 1999 | 60 | 0.010 |
Why?
| | Genes, Viral | 1 | 1998 | 93 | 0.010 |
Why?
| | Rodentia | 1 | 1998 | 45 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2000 | 443 | 0.010 |
Why?
| | Arsenicals | 1 | 1998 | 26 | 0.010 |
Why?
| | Coronary Disease | 1 | 2000 | 355 | 0.010 |
Why?
| | Pyrrolidines | 1 | 1998 | 57 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1999 | 369 | 0.010 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 1999 | 91 | 0.010 |
Why?
| | DNA Replication | 1 | 1999 | 210 | 0.010 |
Why?
| | Foreign-Body Reaction | 1 | 1997 | 23 | 0.010 |
Why?
| | Polyethylene Terephthalates | 1 | 1997 | 15 | 0.010 |
Why?
| | Surface Properties | 1 | 1999 | 397 | 0.010 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1998 | 145 | 0.010 |
Why?
| | Pregnancy, Multiple | 1 | 1977 | 19 | 0.010 |
Why?
| | Nitrobenzenes | 1 | 1997 | 13 | 0.010 |
Why?
| | Polyhydramnios | 1 | 1977 | 18 | 0.010 |
Why?
| | Sulindac | 1 | 1997 | 17 | 0.010 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 1997 | 20 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 1997 | 82 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1997 | 53 | 0.010 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1997 | 72 | 0.010 |
Why?
| | RNA, Neoplasm | 1 | 1997 | 77 | 0.010 |
Why?
| | Adolescent | 2 | 2010 | 18364 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 1997 | 167 | 0.010 |
Why?
| | Aging | 2 | 1998 | 1675 | 0.010 |
Why?
| | Pyelonephritis | 1 | 1975 | 8 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1996 | 204 | 0.010 |
Why?
| | Xanthomatosis | 1 | 1975 | 11 | 0.010 |
Why?
| | Cell Cycle | 1 | 1998 | 547 | 0.010 |
Why?
| | Diatrizoate | 1 | 1975 | 3 | 0.010 |
Why?
| | Caseins | 1 | 1995 | 22 | 0.010 |
Why?
| | Iothalamic Acid | 1 | 1975 | 6 | 0.010 |
Why?
| | Papilloma | 1 | 1995 | 46 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1996 | 332 | 0.010 |
Why?
| | Subtraction Technique | 1 | 1975 | 27 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1994 | 17 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1994 | 24 | 0.010 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1994 | 21 | 0.010 |
Why?
| | Fibroblast Growth Factor 1 | 1 | 1994 | 15 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1994 | 194 | 0.010 |
Why?
| | Integrins | 1 | 1995 | 82 | 0.010 |
Why?
| | Drosophila | 1 | 1996 | 140 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1630 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1996 | 528 | 0.010 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 1 | 1994 | 22 | 0.010 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 1994 | 90 | 0.010 |
Why?
| | Radiography, Interventional | 1 | 1995 | 113 | 0.010 |
Why?
| | Head | 1 | 1975 | 86 | 0.010 |
Why?
| | Lactation | 1 | 1995 | 156 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1993 | 14 | 0.010 |
Why?
| | Culture Media, Serum-Free | 1 | 1993 | 41 | 0.010 |
Why?
| | Radioligand Assay | 1 | 1993 | 45 | 0.010 |
Why?
| | Pyrazoles | 1 | 1997 | 363 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 62 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1975 | 184 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1993 | 133 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2000 | 1343 | 0.010 |
Why?
| | Sulfonamides | 1 | 1997 | 444 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 181 | 0.010 |
Why?
| | Mice, Nude | 1 | 1995 | 662 | 0.010 |
Why?
| | Biological Factors | 1 | 1993 | 41 | 0.010 |
Why?
| | Hepatectomy | 1 | 1993 | 139 | 0.010 |
Why?
| | Movement | 1 | 1975 | 248 | 0.010 |
Why?
| | Cell Count | 1 | 1993 | 315 | 0.010 |
Why?
| | Gastric Juice | 1 | 1992 | 6 | 0.010 |
Why?
| | Hydrochloric Acid | 1 | 1992 | 8 | 0.010 |
Why?
| | Insulin-Like Growth Factor I | 1 | 1994 | 285 | 0.010 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1992 | 29 | 0.010 |
Why?
| | Isoquinolines | 1 | 1992 | 41 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1994 | 804 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 394 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1992 | 193 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1992 | 412 | 0.010 |
Why?
| | Child | 1 | 2010 | 19033 | 0.010 |
Why?
| | Trypsin | 1 | 1990 | 72 | 0.010 |
Why?
| | Piperazines | 1 | 1992 | 316 | 0.010 |
Why?
| | Endopeptidases | 1 | 1990 | 71 | 0.010 |
Why?
| | Disulfides | 1 | 1990 | 91 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1990 | 482 | 0.000 |
Why?
| | Renal Artery | 1 | 1975 | 30 | 0.000 |
Why?
| | Biopsy | 1 | 1975 | 1078 | 0.000 |
Why?
|
|
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|